Immunogenicity and Safety of Recombinant COVID-19 Vaccine (CHO Cells)

计划入组 480 人 · 首次发布于 2021 年 3 月 24 日

Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)

计划入组 450 人 · 首次发布于 2023 年 5 月 9 日

Immunogenicity and Safety Evaluation of Recombinant Novel Coronavirus Vaccine (CHO Cells) in Enhancing Immunity

计划入组 360 人 · 首次发布于 2021 年 10 月 22 日

CHO Cells Recombinant Vaccine

Zoster vaccine recombinant, adjuvanted (CR biopharm)

HN-101

CHO RAY HOSPITAL

India

STEM CELLS ARABIA

Jordan

Personalized Stem Cells, Inc.

United States

Chitose Laboratory and Fujifilm Biosciences Form Strategic Alliance to Advance Biopharmaceutical Manufacturing

CHO Plus Secures U.S. Patent for Engineered Yeast Cell Technology to Boost Protein Production

Asimov Expands Strategic Partnerships to Accelerate Biologics Development Through CHO Edge Platform